XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Stock Appreciation Rights (SARs)
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss)
Total Shareholders' Equity
Non-Controlling Interests
Beginning balance ( in shares) at Dec. 31, 2022   157,682,531          
Beginning balance at Dec. 31, 2022 $ 244,409 $ 698,493   $ (456,120) $ (1,946) $ 240,427 $ 3,982
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) 114,264     114,265   114,265 (1)
Share-based compensation 1,186 $ 1,186       1,186  
Shares issued for exercise of stock appreciation rights (in shares)   34,219          
Shares issued for exercise of stock options (72) $ (72)       (72)  
Shares issued for exercise of stock appreciation rights (in shares)   312,662          
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units 918 $ 918       918  
Ending balance (in shares) at Mar. 31, 2023   158,029,412          
Ending balance at Mar. 31, 2023 359,013 $ 698,833   (341,855) (1,946) 355,032 3,981
Beginning balance ( in shares) at Dec. 31, 2022   157,682,531          
Beginning balance at Dec. 31, 2022 244,409 $ 698,493   (456,120) (1,946) 240,427 3,982
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) 119,849            
Ending balance (in shares) at Sep. 30, 2023   160,463,370          
Ending balance at Sep. 30, 2023 383,328 $ 717,564   (336,153) (1,946) 379,465 3,863
Beginning balance ( in shares) at Mar. 31, 2023   158,029,412          
Beginning balance at Mar. 31, 2023 359,013 $ 698,833   (341,855) (1,946) 355,032 3,981
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) (4,885)     (4,861)   (4,861) (24)
Share-based compensation 1,554 $ 1,554       1,554  
Shares issued for exercise of stock appreciation rights (in shares)   45,126          
Shares issued for exercise of stock options (312) $ (312)       (312)  
Shares issued for exercise of stock appreciation rights (in shares)   164,258          
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units 848 $ 848       848  
Ending balance (in shares) at Jun. 30, 2023   158,238,796          
Ending balance at Jun. 30, 2023 355,146 $ 699,851   (346,716) (1,946) 351,189 3,957
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) 10,469     10,563     (94)
Shares Issued For Cash By At The Market Offering Shares   2,048,172          
Shares issued for cash by at-the-market offering 16,416 $ 16,416       16,416  
Share issuance cost 369 369       369  
Share-based compensation 1,293 $ 1,293       1,293  
Shares issued for exercise of stock appreciation rights (in shares)   100,522          
Shares issued for exercise of stock options (247) $ (247)       (247)  
Shares issued for consulting services (in shares)   70,336          
Shares issued for consulting services 126 $ 126       126  
Shares issued for exercise of stock appreciation rights (in shares)   5,544          
Ending balance (in shares) at Sep. 30, 2023   160,463,370          
Ending balance at Sep. 30, 2023 383,328 $ 717,564   (336,153) (1,946) 379,465 3,863
Beginning balance ( in shares) at Dec. 31, 2023   162,659,155          
Beginning balance at Dec. 31, 2023 379,205 $ 733,450   (356,258) (1,946) 375,246 3,959
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) 3,638     3,639   3,639 (1)
Shares Issued For Cash By At The Market Offering Shares   619,910          
Shares issued for cash by at-the-market offering 4,898 $ 4,898       4,898  
Share issuance cost 110 110       110  
Share-based compensation 1,345 $ 1,345       1,345  
Shares issued for exercise of stock appreciation rights (in shares)   29,116 89,794        
Cash paid to settle and fund employee income tax withholding due upon exercise of stock appreciation rights (552) $ (552)       (552)  
Shares issued for exercise of stock options (103) $ (103)       (103)  
Shares issued for the vesting of restricted stock units (in shares)   253,922          
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units 837 $ 837       837  
Ending balance (in shares) at Mar. 31, 2024   163,651,897          
Ending balance at Mar. 31, 2024 387,690 $ 738,297   (352,619) (1,946) 383,732 3,958
Beginning balance ( in shares) at Dec. 31, 2023   162,659,155          
Beginning balance at Dec. 31, 2023 379,205 $ 733,450   (356,258) (1,946) 375,246 3,959
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) (14,860)            
Ending balance (in shares) at Sep. 30, 2024   164,678,756          
Ending balance at Sep. 30, 2024 376,687 $ 745,792   (371,097) (1,946) 372,749 3,938
Beginning balance ( in shares) at Mar. 31, 2024   163,651,897          
Beginning balance at Mar. 31, 2024 387,690 $ 738,297   (352,619) (1,946) 383,732 3,958
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) (6,419)     (6,418)   (6,418) (1)
Share-based compensation 1,412 $ 1,412       1,412  
Shares issued for exercise of stock appreciation rights (in shares)   9,214          
Shares issued for exercise of stock options (53) $ (53)       (53)  
Ending balance (in shares) at Jun. 30, 2024   163,661,111          
Ending balance at Jun. 30, 2024 382,736 $ 739,762   (359,037) (1,946) 378,779 3,957
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) (12,079)     (12,060)   (12,060) (19)
Share-based compensation 1,027 $ 1,027       1,027  
Shares issued for exercise of stock appreciation rights (in shares)   9,474          
Shares issued for exercise of stock options (3) $ (3)       (3)  
Shares issued for acquisition of intangible assets (in shares)   321,197          
Shares issued for acquisition of intangible assets 1,500 $ 1,500       1,500  
Shares issued for joint venture interests (shares)   686,974          
Shares issued for joint venture interests 3,500 $ 3,500       3,500  
Ending balance (in shares) at Sep. 30, 2024   164,678,756          
Ending balance at Sep. 30, 2024 $ 376,687 $ 745,792   $ (371,097) $ (1,946) $ 372,749 $ 3,938